Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Jan 25 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.23 | 60,000 | 73.80 k | 60,000 |
24 Dec 24 | GALT Galectin Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.8164 | 10,000 | 8.16 k | 42,083 |
23 Aug 24 | GALT Galectin Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.3 | 1,759 | 4.05 k | 32,083 |
23 Aug 24 | GALT Galectin Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 2.3 | 1,000 | 2.30 k | 2,000 |
22 Aug 24 | GALT Galectin Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.3 | 741 | 1.70 k | 30,324 |
30 Apr 24 | GALT Galectin Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.52 | 1,000 | 3.52 k | 1,000 |
24 Jan 24 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.72 | 50,000 | 86.00 k | 50,000 |